Embecta Corp. Declares Quarterly Cash Dividend of $0.15 Per Share

Embecta Corp. announces a quarterly cash dividend of $0.15 per share, payable December 18, 2025.

Quiver AI Summary

Embecta Corp. has announced a quarterly cash dividend of $0.15 per share, which will be paid on December 18, 2025, to stockholders of record as of December 5, 2025. The company, which has a long history in insulin delivery, aims to expand its role as a medical supplies provider focused on enhancing lives through innovation and collaboration. Embecta employs around 2,000 people globally and encourages interested parties to learn more through their website and social media platforms.

Potential Positives

The declaration of a quarterly cash dividend of $0.15 per share demonstrates the company's commitment to returning value to its shareholders.
The upcoming dividend payment is indicative of the company's positive financial health and sustainability, which can boost investor confidence.
This move can attract potential investors looking for dividend-paying stocks, enhancing market interest in Embecta Corp.
The press release highlights the company's long-standing dedication to innovation and healthcare, reinforcing its position in the medical supplies industry.

Potential Negatives

Declaring a cash dividend may indicate that the company is prioritizing shareholder returns over reinvestment in growth initiatives, which could limit future expansion opportunities.
The amount of the dividend ($0.15) may be viewed as insufficient or disappointing by investors, potentially leading to negative perceptions of the company's financial health and growth prospects.
The timing of the dividend distribution, just before the holidays, might be seen as an attempt to boost share prices temporarily, raising concerns about the company's long-term stability and strategies.

FAQ

What is the declared dividend amount by Embecta Corp.?

The Board of Directors of Embecta Corp. has declared a quarterly cash dividend of $0.15 per share.

When will the dividend be paid to stockholders?

The dividend is payable on December 18, 2025, to stockholders of record as of December 5, 2025.

What is the purpose of Embecta Corp.?

Embecta Corp. aims to advance its legacy in insulin delivery and expand into a broad-based medical supplies company.

How many employees does Embecta Corp. have worldwide?

Embecta Corp. employs approximately 2,000 individuals globally.

Where can I find more information about Embecta Corp.?

More information about Embecta Corp. can be found on their website at embecta.com and their social media channels.

Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.

$EMBC Hedge Fund Activity

We have seen 119 institutional investors add shares of $EMBC stock to their portfolio, and 213 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

JEFFERIES FINANCIAL GROUP INC. added 542,162 shares (+40.4%) to their portfolio in Q3 2025, for an estimated $7,649,905
SEI INVESTMENTS CO removed 406,274 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $3,936,795
MILLENNIUM MANAGEMENT LLC removed 388,531 shares (-21.3%) from their portfolio in Q3 2025, for an estimated $5,482,172
QUBE RESEARCH & TECHNOLOGIES LTD removed 362,935 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $5,121,012
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC removed 312,857 shares (-15.7%) from their portfolio in Q3 2025, for an estimated $4,414,412
KENT LAKE PR LLC removed 306,927 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $2,974,122
MORGAN STANLEY removed 303,019 shares (-25.1%) from their portfolio in Q3 2025, for an estimated $4,275,598

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$EMBC Analyst Ratings

Wall Street analysts have issued reports on $EMBC in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

BTIG issued a "Buy" rating on 09/05/2025

To track analyst ratings and price targets for $EMBC, check out Quiver Quantitative's $EMBC forecast page.

$EMBC Price Targets

Multiple analysts have issued price targets for $EMBC recently. We have seen 2 analysts offer price targets for $EMBC in the last 6 months, with a median target of $18.5.

Here are some recent targets:

Marie Thibault from BTIG set a target price of $25.0 on 09/05/2025
Anthony Petrone from Mizuho set a target price of $12.0 on 07/16/2025

Full Release

PARSIPPANY, N.J., Nov. 25, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. (“embecta”) (Nasdaq: EMBC) has declared a quarterly cash dividend of $0.15 for each issued and outstanding share of the Company’s common stock. The dividend is payable on December 18, 2025 to stockholders of record at the close of business on December 5, 2025.

About embecta
embecta is a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, helping to improve lives through innovative solutions, partnerships, and the passion of approximately 2,000 employees around the globe. For more information, visit embecta.com or follow our social channels on LinkedIn , Facebook , and Instagram .

Contacts:

Media	Investors
Christian Glazar	Pravesh Khandelwal
Sr. Director, Corporate Communications	VP, Head of Investor Relations
908-821-6922	551-264-6547
Contact Media Relations	Contact IR